SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medicamen Biotech informs about board meeting

22 May 2023 Evaluate

Pursuant to Regulation 29 read with Regulation 33 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Medicamen Biotech has informed that a Meeting of the Board of Directors of the company is scheduled to be held on Monday, May 29, 2023 at the registered office of the Company situated at 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi-110019 to consider and approve the following business(s): The Audited Financial Results of the Company (Standalone and Consolidated) for the quarter / year ended on March 31, 2023, to consider the recommendation of Final Dividend on Equity Shares of the Company for the financial year 2022-23, to consider and appoint SPB & Co, Cost Accountants, as the Cost Auditor of the company for the financial year 2023-24, to consider and appoint Cheena & Associates, as the Internal Auditor of the company for the financial year 2023- 24, to consider and appoint AMJ & Associates, as the Secretarial Auditor of the company for the financial year 2023- 24 and any other business with the permission of the chair. In this connection, in reference to its letter dated March 21, 2023, wherein it was informed that pursuant to the Company's Code of Conduct framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and amendments made there under, the trading window for dealing in the shares of the Company is closed for all designated persons of the Company from the March 21, 2023 and will open 48 hours after the said Financial Results are declared to the stock exchanges.

The above information is a part of company’s filings submitted to BSE.

Medicamen Biotech Share Price

257.10 -11.20 (-4.17%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×